Protein microarrays discover angiotensinogen and PRKRIP1 as novel targets for autoantibodies in chronic renal disease

Molecular and Cellular Proteomics

Volumn 10, Issue 3, 2011, Pages

  Butte, Atul J ^a,b   Sigdel, Tara K ^a   Wadia, Persis P ^a   Miklos, David B ^a   Sarwal, Minnie M ^b  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LUCILE PACKARD CHILDREN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSINOGEN; AUTOANTIBODY; PROTEIN KINASE R; PROTEIN KINASE R INTERACTING PROTEIN 1; UNCLASSIFIED DRUG; PHOSPHOPEPTIDE; PHOSPHOPROTEIN; PRKRIP1 PROTEIN, MOUSE; PROTEOME; RNA BINDING PROTEIN;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY TITER; ANTIGEN BINDING; ARTICLE; CHILD; CHRONIC KIDNEY DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; INFANT; KIDNEY FAILURE; MALE; NUCLEOTIDE SEQUENCE; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEIN TARGETING; SCHOOL CHILD; AMINO ACID SEQUENCE; ANIMAL; CELL DIFFERENTIATION; CHEMISTRY; CHRONIC KIDNEY FAILURE; CYTOLOGY; EMBRYONIC STEM CELL; IMMUNOLOGY; METABOLISM; METHODOLOGY; MOLECULAR GENETICS; MOUSE; PHOSPHORYLATION; PROTEIN MOTIF;

AMINO ACID MOTIFS; AMINO ACID SEQUENCE; ANGIOTENSINOGEN; ANIMALS; AUTOANTIBODIES; CELL DIFFERENTIATION; EMBRYONIC STEM CELLS; HUMANS; KIDNEY FAILURE, CHRONIC; MICE; MOLECULAR SEQUENCE DATA; PHOSPHOPEPTIDES; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN ARRAY ANALYSIS; PROTEOME; RNA-BINDING PROTEINS;

EID: 79953191841     PISSN: 15359476     EISSN: 15359484     Source Type: Journal    
DOI: 10.1074/mcp.M110.000497     Document Type: Article

References (39)

1. Lewis, E. J., Hunsicker, L. G., Clarke, W. R., Berl, T., Pohl, M. A., Lewis, J. B., Ritz, E., Atkins, R. C., Rohde, R., and Raz, I. (2001) Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes. N. Engl. J. Med. 345, 851-860
2. Casas, J. P., Chua, W., Loukogeorgakis, S., Vallance, P., Smeeth, L., Hingorani, A. D., and MacAllister, R. J. (2005) Effect of inhibitors of the renin-angiotensin system and other antihypertensive drugs on renal outcomes: systematic review and meta-analysis. Lancet 366, 2026-2033 (Pubitemid 41773378)
3. Gutierrez, O. M., Mannstadt, M., Isakova, T., Rauh-Hain, J. A., Tamez, H., Shah, A., Smith, K., Lee, H., Thadhani, R., Juppner, H., and Wolf, M. (2008) Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N. Engl. J. Med. 359, 584-592
4. Postorino, M., Marino, C., Tripepi, G., and Zoccali, C. (2008) Gammaglutamyltransferase in ESRD as a predictor of all-cause and cardiovascular mortality: another facet of oxidative stress burden. Kidney Int. 111, Suppl. S64-66
5. Svensson, M., Gorst-Rasmussen, A., Schmidt, E. B., Jorgensen, K. A., and Christensen, J. H. (2009) NT-pro-BNP is an independent predictor of mortality in patients with end-stage renal disease. Clin. Nephrol. 71, 380-386
6. Jorsal, A., Tarnow, L., Flyvbjerg, A., Parving, H. H., Rossing, P., and Rasmussen, L. M. (2008) Plasma osteoprotegerin levels predict cardiovascular and all-cause mortality and deterioration of kidney function in type 1 diabetic patients with nephropathy. Diabetologia 51, 2100-2107
7. Kovesdy, C. P., George, S. M., Anderson, J. E., and Kalantar-Zadeh, K. (2009) Outcome predictability of biomarkers of protein-energy wasting and inflammation in moderate and advanced chronic kidney disease. Am. J. Clin. Nutr 90, 407-414
8. Malyszko, J., Malyszko, J. S., Bachorzewska-Gajewska, H., Poniatowski, B., Dobrzycki, S., and Mysliwiec, M. (2009) Neutrophil gelatinase-associated lipocalin is a new and sensitive marker of kidney function in chronic kidney disease patients and renal allograft recipients. Transplant Proc. 41, 158-161
9. Bolignano, D., Lacquaniti, A., Coppolino, G., Donato, V., Campo, S., Fazio, M. R., Nicocia, G., and Buemi, M. (2009) Neutrophil gelatinase-associated lipocalin (NGAL) and progression of chronic kidney disease. Clin. J. Am. Soc. Nephrol. 4, 337-344
10. Snaedal, S., Heimburger, O., Qureshi, A. R., Danielsson, A., Wikstrom, B., Fellstrom, B., Fehrman-Ekholm, I., Carrero, J. J., Alvestrand, A., Stenvinkel, P., and Barany, P. (2009) Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: implications for patient survival. Am. J. Kidney Dis. 53, 1024-1033
11. Meier, P., Golshayan, D., Blanc, E., Pascual, M., and Burnier, M. (2009) Oxidized LDL modulates apoptosis of regulatory T cells in patients with ESRD. J. Am. Soc. Nephrol. 20, 1368-1384
12. Yilmaz, M. I., Axelsson, J., Sonmez, A., Carrero, J. J., Saglam, M., Eyileten, T., Caglar, K., Kirkpantur, A., Celik, T., Oguz, Y., Vural, A., Yenicesu, M., Lindholm, B., and Stenvinkel, P. (2009) Effect of renin angiotensin system blockade on pentraxin 3 levels in type-2 diabetic patients with proteinuria. Clin. J. Am. Soc. Nephrol. 4, 535-541
13. Manchanda, P. K., Singh, R., and Mittal, R. D. (2009) Cytokine (IL-10 -1082 and -819) and chemokine receptor (CCR2 and CCR5) gene polymorphism in North Indian patients with end-stage renal disease. DNA Cell Biol. 28, 177-183
14. Hudson, M. E., Pozdnyakova, I., Haines, K., Mor, G., and Snyder, M. (2007) Identification of differentially expressed proteins in ovarian cancer using high-density protein microarrays. Proc. Natl. Acad. Sci. U. S. A. 104, 17494-17499
15. Robinson, W. H., DiGennaro, C., Hueber, W., Haab, B. B., Kamachi, M., Dean, E. J., Fournel, S., Fong, D., Genovese, M. C., de Vegvar, H. E. N., Skriner, K., Hirschberg, D. L., Morris, R. I., Muller, S., Pruijn, G. J., van Venrooij, W. J., Smolen, J. S., Brown, P. O., Steinman, L., and Utz, P. J. (2002) Autoantigen microarrays for multiplex characterization of autoantibody responses. Nat. Med. 8, 295-301
16. Li, L., Wadia, P., Chen, R., Kambham, N., Naesens, M., Sigdel, T. K., Miklos, D. B., Sarwal, M. M., and Butte, A. J. (2009) Identifying compartment-specific non-HLA targets after renal transplantation by integrating transcriptome and "antibodyome" measures. Proc. Natl. Acad. Sci. U. S. A. 106, 4148-4153
17. Schwartz, G. J., Haycock, G. B., Edelmann, C. M., Jr., and Spitzer, A. (1976) A simple estimate of glomerular filtration rate in children derived from body length and plasma creatinine. Pediatrics 58, 259-263
18. Sutherland, S. M., Li, L., Sigdel, T. K., Wadia, P. P., Miklos, D. B., Butte, A. J., and Sarwal, M. M. (2009) Protein microarrays identify antibodies to protein kinase Czeta that are associated with a greater risk of allograft loss in pediatric renal transplant recipients. Kidney Int. 76, 1277-1283
19. Sing, T., Sander, O., Beerenwinkel, N., and Lengauer, T. (2005) ROCR: visualizing classifier performance in R. Bioinformatics 21, 3940-3941 (Pubitemid 41535515)
20. Yin, Z., Haynie, J., Williams, B. R., and Yang, Y. C. (2003) C114 is a novel IL-11-inducible nuclear double-stranded RNA-binding protein that inhibits protein kinase R. J. Biol. Chem. 278, 22838-22845
21. Lai, P. C., Smith, J., Bhangal, G., Chaudhry, K. A., Chaudhry, A. N., Keith, J. C., Jr., Tam, F. W., Pusey, C. D., and Cook, H. T. (2005) Interleukin-11 reduces renal injury and glomerular NF-kappa B activity in murine experimental glomerulonephritis. Nephron Exp. Nephrol. 101, e146-e154
22. Komatsu, M., Waguri, S., Ueno, T., Iwata, J., Murata, S., Tanida, I., Ezaki, J., Mizushima, N., Ohsumi, Y., Uchiyama, Y., Kominami, E., Tanaka, K., and Chiba, T. (2005) Impairment of starvation-induced and constitutive autophagy in Atg7-deficient mice. J. Cell Biol. 169, 425-434 (Pubitemid 40686693)
23. Yu, W., Imoto, I., Inoue, J., Onda, M., Emi, M., and Inazawa, J. (2007) A novel amplification target, DUSP26, promotes anaplastic thyroid cancer cell growth by inhibiting p38 MAPK activity. Oncogene 26, 1178-1187
24. Morris, B. J., Catanzaro, D. F., Hardman, J., Mesterovic, N., Tellam, J., Hort, Y., Bennetts, B. H., and Shine, J. (1984) Structure of human renin and expression of the renin gene. Clin. Exp. Pharmacol. Physiol. 11, 369-373
25. Niimura, F., Labosky, P. A., Kakuchi, J., Okubo, S., Yoshida, H., Oikawa, T., Ichiki, T., Naftilan, A. J., Fogo, A., Inagami, T., et al. (1995) Gene targeting in mice reveals a requirement for angiotensin in the development and maintenance of kidney morphology and growth factor regulation. J. Clin. Invest. 96, 2947-2954
26. Brenner, B. M., Cooper, M. E., de Zeeuw, D., Keane, W. F., Mitch, W. E., Parving, H. H., Remuzzi, G., Snapinn, S. M., Zhang, Z., and Shahinfar, S. (2001) Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy. N. Engl. J. Med. 345, 861-869
27. Ketteler, M., Noble, N. A., and Border, W. A. (1995) Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis? Annu. Rev. Physiol. 57, 279-295
28. Wolf, G. (2006) Renal injury due to renin-angiotensin-aldosterone system activation of the transforming growth factor-beta pathway. Kidney Int. 70, 1914-1919
29. Seccia, T. M., Maniero, C., Belloni, A. S., Guidolin, D., Pothen, P., Pessina, A. C., and Rossi, G. P. (2008) Role of angiotensin II, endothelin-1 and L-type calcium channel in the development of glomerular, tubulointerstitial and perivascular fibrosis. J. Hypertens. 26, 2022-2029
30. Moore, T. J., Lazarus, J. M., and Hakim, R. M. (1989) Reduced angiotensin receptors and pressor responses in hypotensive hemodialysis patients. Kidney Int. 36, 696-701
31. Makarious, M., Pawlak, M., Campbell, L. V., Timmermans, V., Duggan, K., Charlesworth, J. A., and Macdonald, G. J. (1993) The platelet angiotensin II receptor in type I diabetes: studies in patients with and without nephropathy. Eur. J. Clin. Invest. 23, 517-521
32. Gardiner, S. M., Auton, T. R., Downham, M. R., Sharp, H. L., Kemp, P. A., March, J. E., Martin, H., Morgan, P. J., Rushton, A., Bennett, T., and Glover, J. F. (2000) Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats. Br. J. Pharmacol. 129, 1178-1182
33. Miller, S. A., Accardi, J. R., and St Onge, E. L. (2008) Angiotensin II vaccine: a novel approach in the treatment of hypertension. Expert Opin. Biol. Ther. 8, 1669-1673
34. Pandey, R., Quan, W. Y., Hong, F., and Jie, S. L. (2009) Vaccine for hypertension: modulating the renin-angiotensin system. Int. J. Cardiol. 134, 160-168
35. Campbell, D. J. (2009) Angiotensin vaccination: what is the prospect of success? Curr. Hypertens. Rep. 11, 63-68
36. Dechend, R., Homuth, V., Wallukat, G., Muller, D. N., Krause, M., Dudenhausen, J., Haller, H., and Luft, F. C. (2006) Agonistic antibodies directed at the angiotensin II, AT1 receptor in preeclampsia. J. Soc. Gynecol. Investig. 13, 79-86
37. Xia, Y., Ramin, S. M., and Kellems, R. E. (2007) Potential roles of angiotensin receptor-activating autoantibody in the pathophysiology of preeclampsia. Hypertension 50, 269-275
38. Boon, V. A., Munro, J. L., Kan, G. W., Burnell, J., and Speare, R. (2008) Seroreactivity against streptococcal DRS (distantly related to SIC) protein is a predictor for end-stage renal failure. Clin. Vaccine Immunol. 15, 1699-1704
39. Afaneh, C., Muthukumar, T., Lubetzky, M., Ding, R., Snopkowski, C., Sharma, V. K., Seshan, S., Dadhania, D., Schwartz, J. E., and Suthanthiran, M. Urinary Cell Levels of mRNA for OX40, OX40L, PD-1, PD-L1, or PD-L2 and Acute Rejection of Human Renal Allografts. Transplantation. 9, 1381-1387